Treatment of chronic post-radiation cystitis with trans-urethral amniotic bladder therapy appears durable at 9 months: A clinical study.
Jonathan LutchkaJack VercnockeEmily FisherCodrut RadoiuJulian JeberaeelSteven LucasNivedita DharPublished in: Urologia (2024)
Our data suggest that a significant number of CRC patients may have durable benefit after ABT. Despite this, some of them can show symptoms rebound at 24 weeks.